Travere Therapeutics: Tricky Outlook Gives Me Pause For Thought - Downgrade
Travere Therapeutics' Filspari boosts revenue with FDA approval, but heavy losses and competitive threats raise concerns for ...
pharmaphorum3d
The challenge of transparency in the global supply chain
As recently as January this year the blood pressure medication Irbesartan Hydrochlorothiazide ... a blood-pressure generic, among fears that it contained the carcinogenic, N-Nitrosodimethylamine ...
pharmaphorum1d
A history of Bristol-Myers Squibb
This was largely due to the US patent expiration of high blood pressure drug, Avapro / Avalide (irbesartan), in March 2012, followed by blood clot treatment Plavix (clopidogrel) in May 2012.
Canada4d
Drug shortages in Canada
A drug shortage is when a drug manufacturer isn't able to supply enough of a drug to meet all of its Canadian orders on time. The words drug, medication and medicine are often used interchangeably.